The impact of antiseizure medications on polysomnographic parameters: a systematic review and meta-analysis

• Published in: Sleep medicine 2021-05, Vol.81, p.319-326
• Main Authors: Yeh, Wei-Chih, Lu, Shiang-Ru, Wu, Meng-Ni, Lee, Kuo-Wei, Chien, Ching-Fang, Fong, Yi-On, Li, Kuan-Ying, Lai, You-Lin, Lin, Chiu-Jung, Li, Ying-Sheng, Su, Chien-Yu, Wang, Yu-Chun, Lin, Yu-Han, Chen, Tien-Yu, Tseng, Ping-Tao, Hsu, Chung-Yao
• Format: Article
• Language: English
• Subjects: Antiseizure medications; Humans; Meta-analysis; Polysomnography; REM sleep; Sleep; Sleep, REM; Slow wave sleep
• ISSN: 1389-9457; 1878-5506
• DOI: 10.1016/j.sleep.2021.02.056

Oral antiseizure medications (ASMs) are first-line treatments for patients with epilepsy. However, ASMs may alter sleep architecture, adversely affecting patient outcomes. The meta-analysis aimed to elucidate the effect of ASMs on sleep architecture. PubMed, Embase, and Cochrane Central database (up to Febrary 2021) were searched for randomized control trials (RCT) with effects of ASMs on polysomnography parameters. A meta-analysis using a random-effects model was performed. We did not set limitation to the participants with underlying diagnosis of epilepsy. Eighteen randomized-controlled trials fulfilled the eligibility criteria. The effects of five main groups of ASMs (sodium channel blockers, calcium channel blockers, GABA enhancers, synaptic vesicle glycoprotein 2A [SV2A] ligand, and broad-spetrum ASMs) on slow-wave sleep (SWS), rapid eye movement (REM) sleep, and sleep efficiency (SE) were analyzed. Compared with placebo, calcium channel blockers and GABA enhancers significantly increased SWS. GABA enhancers also decreased REM sleep percentage, whereas calcium channel blockers significantly increased SE. Sodium channel blockers, SV2A ligand and broad-spectrum ASMs did not affect SWS, REM sleep, or SE. The subgroup analysis revealed that gabapentin, pregabalin, and tiagabine increased the percentage of SWS. Tiagabine also decreased REM sleep, whereas pregabalin increased SE. Finally, levetiracetam did not affect SWS, REM sleep, and SE. This meta-analysis indicated that ASMs can have a statistically significant effect on sleep parameters; the effect differs between ASMs. •Calcium channel blockers (CCB) and GABA enhancers increased SWS.•GABA enhancers decreased REM sleep percentage, whereas CCB increased SE.•Gabapentin, pregabalin, and tiagabine increased the percentage of SWS.•Tiagabine decreased REM sleep, whereas pregabalin increased SE.•Levetiracetam did not affect SWS, REM sleep, and SE.